The Olympic Games dont get started in London until next week, but theres already a bit of a competitive spirit in the top medical imaging headlines from this week. Which hospital ranks number one in the U.S.? Can the iPad stand up to secondary-class LCD monitors when viewing MRIs? Which enterprise imaging strategy came out on top in a survey of providers?

Crux Biomedicals vena cava filter has received FDA clearance for the prevention of recurrent pulmonary embolisms.

Researchers at Stony Brook University in New York have demonstrated an ultrasound-based method to promote bone cell growth, and the technique could eventually lead to non-pharmacologic treatments of osteoporosis, fractures and other conditions involving bone loss.

Siemens Healthcare has introduced the Acuson P300 ultrasound system.

As the number and type of breast imaging modalities have multiplied and research has demonstrated their effectiveness, it may be time for womens imaging practices to consider the role of new technologies in breast cancer screening and detection.

For years, radiology leaders have exhorted radiologists to get out of the reading room and communicate with clinicians. More recently, the message has extended to include patients, evidenced by the American College of Radiologys Face of Radiology campaign to educate patients about the role of radiologists in the healthcare process. Some have lobbied for direct communication of radiology results to patients. Yet, for many patients, radiologists remain invisible, anonymous and silent.

The FDA has assigned a priority review designation to the supplemental New Drug Applications for rivaroxaban (Xarelto), an oral anticoagulant seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE) and to prevent their recurrence, Janssen Research & Development announced July 9.

Carestream has introduced software for three of its DRX digital radiography systems.